RenovaCare products are under development and not approved for sale in the United States.

Results may vary from person to person.

RenovaCare products are under development and not approved for sale in the United States.

Results may vary from person to person.

Latest Press Releases

RenovaCare Chairman Invests $15.5 Million to Fund SkinGun Regulatory Submissions and Clinical Trials

Scottsdale, AZ– November 29th, 2018 - RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to over $20 million.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company's commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
94 Hundred Corporate Center,
9375 E Shea Blvd, Suite 107-A
Scottsdale, AZ 85260
1-888-398-0202

Sign Up for Investor Alerts

Sign Up for Investor Alerts